What Oncologists Need to Know about Biosimilars
May 15, 2018•26 min•Ep. 7
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Dr. Gary Lyman, MPH, FASCO, FRCP, joins ASCO CEO Dr. Clifford A. Hudis to discuss biosimilars and ASCO's recent statement on biosimilars published in the Journal of Clinical Oncology.
For the best experience, listen in Metacast app for iOS or Android